Masashi Tachibana
15PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Jul 10, 2025
Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity.Ryosuke Ono, Sora Tokuoka, Masashi Tachibana
|Feb 01, 2025
HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells.Zhiqi Xie, Jinjin Shao, Zeren Shen
|Jan 12, 2023
Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models.Maaya Morita, Aki Yoneda, Nagisa Tokunoh
|Jun 24, 2022
Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors.Sachiko Hirobe, Seina Nagai, Masashi Tachibana
|Apr 12, 2022
The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity.Sachiko Hirobe, Keisuke Imaeda, Masashi Tachibana
|Feb 26, 2022
Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells.Sachiko Hirobe, Taki Yamasaki, Sayami Ito
Pageof 3
Frequent Collaborators
4 joint publications
Naoki Okada
3 joint publications
Sachiko Hirobe
2 joint publications
Hiroyuki Mizuguchi
2 joint publications
Ken J Ishii
1 joint publications
Kouji Kobiyama
1 joint publications
So-Ichiro Fukada
1 joint publications
Keisuke Shirakura
1 joint publications
Rina Hashimoto
1 joint publications
Masahito Ikawa
1 joint publications
Yoshiaki Kubota
